Exelixis Inc (EXEL)
- Exchange
- NASDAQ
- Symbol
- EXEL
- Sector
- Trade & Services
- Industry
- Services-commercial Physical & Biological Research
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, is focused on the discovery, development, and commercialization of new drugs to treat cancers in the United States. The company is headquartered in Alameda, California.
- Country
- USA
Stock price
At close: August 28, 2025
-
Open38.42
-
High38.57
-
Low37.63
-
Close37.90
-
Volume2,245,160
Financial ratios
Dec 31, 2024